MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 09-05-2025
Phreesia Long-Term Debt 2011-2025 | PHR
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt Phreesia
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.15 M | 2.72 M | 7.42 M | 6.47 M | 19.4 M | 27.9 M | 19.5 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 27.9 M | 2.72 M | 12.4 M |
Quarterly Long-Term Debt Phreesia
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.3 M | 1.63 M | 2.32 M | - | 2.88 M | 3.66 M | 3.88 M | 309 K | 2.72 M | 183 K | 158 K | 544 K | 1.63 M | 504 K | 469 K | 781 K | 19.4 M | 22.9 M | 23.5 M | 19.5 M | 27.9 M | 19.4 M | 19.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 27.9 M | 158 K | 7.94 M |
Long-Term Debt of other stocks in the Health information services industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
1.61 B | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
195 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
1.01 B | - | - | $ 2.94 B | USA |
 |
Accolade
ACCD
|
72.3 M | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
7.45 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
240 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
878 M | - | - | $ 6.37 B | USA |
 |
Change Healthcare
CHNG
|
4.58 B | - | - | $ 9.03 B | USA |
 |
Evolent Health
EVH
|
413 M | $ 4.11 | -0.48 % | $ 385 M | USA |
 |
Health Catalyst
HCAT
|
151 M | $ 2.34 | -4.82 % | $ 141 M | USA |
 |
HealthStream
HSTM
|
17.4 M | $ 24.4 | 0.95 % | $ 741 M | USA |
 |
iCAD
ICAD
|
133 K | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
1.41 M | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
875 M | $ 96.06 | -0.75 % | $ 8.22 B | USA |
 |
OptimizeRx Corporation
OPRX
|
34.2 M | $ 13.18 | -1.35 % | $ 226 M | USA |
 |
American Well Corporation
AMWL
|
4.51 M | $ 4.68 | 1.3 % | $ 70.2 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
350 M | - | -10.39 % | $ 886 M | USA |
 |
Progyny
PGNY
|
16.4 M | $ 26.39 | -1.2 % | $ 2.26 B | USA |
 |
Premier
PINC
|
280 M | $ 28.26 | - | $ 2.33 B | USA |
 |
MTBC
MTBC
|
336 K | - | -0.58 % | $ 51.7 M | USA |
 |
GoodRx Holdings
GDRX
|
487 M | $ 2.72 | -3.72 % | $ 1.05 B | USA |
 |
Schrödinger
SDGR
|
101 M | $ 18.41 | 1.99 % | $ 1.34 B | USA |
 |
Omnicell
OMCL
|
31.1 M | $ 43.31 | -1.25 % | $ 1.99 B | USA |
 |
1Life Healthcare
ONEM
|
270 M | - | - | $ 3.37 B | USA |
 |
Signify Health
SGFY
|
333 M | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
755 M | - | - | $ 3.81 B | USA |
 |
10x Genomics
TXG
|
83.8 M | $ 15.77 | 2.01 % | $ 1.85 B | USA |
 |
NantHealth
NH
|
4.05 M | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
18.5 M | - | - | $ 1.6 B | USA |
 |
Veeva Systems
VEEV
|
46.4 M | $ 219.17 | -1.81 % | $ 35.2 B | USA |
 |
Streamline Health Solutions
STRM
|
8.96 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
991 M | $ 7.36 | -2.65 % | $ 1.26 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
12.8 M | - | - | $ 255 M | USA |